Treatment of respiratory chain disorders with compounds having erythropoietin activity or thrombopoietin activity

摘要

Methods of treating mitochondrial respiratory chain disorders using compounds having erythropoietin activity or thrombopoietin activity are disclosed. Indicators for assessing the efficacy of treatment are discussed.